Cancer of mouth of the uterus-Prevention is possible by screening and treatment of precancers

Evaluation of Screen and Treat strategy in a Hybrid capture2(HC2)test and Visual Inspection on Acetic acid(VIA)based cervical cancer screening program - CCSP

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/06/008731

Enrollment

350

Registered

2017-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Cryotherapy procedure of ablative method for treatment of cervical neoplasias: Treatment to the screen positive women by simple and inexpensive ablative treatment at the same sitting r

Eligibility

Inclusion criteria

Inclusion criteria: All women between 30-60 years with intact uterus are eligible for study.

Exclusion criteria

Exclusion criteria: 1.Pregnancy 2.Past history of treatment received for cervical pre cancers and/or cancer

Design outcomes

Primary

Measure	Time frame
The Cryotherapy and the thermo-coagulation arms will be compared by the following parameters: a. % of VIA/HPV positive women having no lesion at follow up at 9-12 months after treatment as verified by colposcopy and/or biopsy b. % of histopathology proved CIN lesions are cured after treatment as verified by colposcopy and/or biopsy c. % of women having complications after treatment Timepoint: Total study duration is 2 years(1 year for recruitment 1 year for follow up)	—

Measure

Time frame

The Cryotherapy and the thermo-coagulation arms will be compared by the following parameters: a. % of VIA/HPV positive women having no lesion at follow up at 9-12 months after treatment as verified by colposcopy and/or biopsy b. % of histopathology proved CIN lesions are cured after treatment as verified by colposcopy and/or biopsy c. % of women having complications after treatment Timepoint: Total study duration is 2 years(1 year for recruitment 1 year for follow up)

—

Secondary

Measure	Time frame
d.% of women agrees to recommend the test to others Timepoint: 1 year	—

Countries

India

Contacts

Public ContactDipanwita Banerjee

Chittaranjan National Cancer Institute

dr.dipanwita@yahoo.co.in9830303500

Outcome results